How can we help reduce global HIV transmissions and improve treatment?
Fighting infectious diseases affecting children and pregnant women
Challenge
Changes in the HIV epidemic and the emergence of new infectious diseases present ongoing research challenges. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) funds research addressing those challenges, including research on the Zika virus, HIV-associated co-infections in children and pregnant women, and more.
Since 1987, Westat has supported NICHD by managing its Coordinating Center, which oversees the NICHD Network of clinical sites in the U.S., South America, Asia, and Africa.
Solution
We develop, monitor, and manage all aspects of Network studies, including:
- Protocol development
- Regulatory management and oversight
- Negotiation and management of subcontracts
- Data management and analysis
- Clinical monitoring
- Acquisition and distribution of investigational products
We also review datasets, write manuscripts and abstracts for publication, and prepare presentations for scientific meetings.
Results
Since its inception, the Network has participated in more than 125 clinical studies, adding 25 protocols in the past 5 years. These protocols have included Phase I to IV trials that evaluate the short- and long-term effects of therapies to:
- Reduce mother-to-infant HIV transmission
- Improve the quality of life and survival of HIV-infected children and adolescents
- Prevent or mitigate the development of the serious outcomes of pediatric and adolescent HIV infection
Focus Areas
Clinical Research Clinical Trials International Health Public Health Real-World Data and EvidenceCapabilities
Biostatistics and Epidemiology Data Management Technical AssistanceSenior Expert Contacts
Isabel Trejos
Principal Research Associate
Kathryn A. Myers
Principal Research Associate
-
Expert Interview
Safeguarding Data Privacy: Innovations at WestatOctober 2025
Protecting the privacy of people who respond to surveys and censuses is a critical responsibility in federal data collection. During the 2010 Decennial Census, the…
-
Expert Interview
Novel Strategies Transform Clinical Trials Into Future OpportunitiesOctober 2025
For the rigorous evaluation of novel medicines, clinical trials are essential to ensure safety and efficacy. However, clinical trials are experiencing turbulent times due to…
-
Expert Interview
Real-World Insights: Nirsevimab’s Protection Against RSV in InfantsSeptember 2025
Each year in the U.S., respiratory syncytial virus, commonly known as RSV, leads to approximately 58,000 to 80,000 hospitalizations among children under age 5. The…